⬆
✘
 
By continuing to use the site, you allow the use of Cookies and agree to the privacy policy.
.,о.,р..и.:г,.и.,н.;н.,а;,л.. .,н.:а,.х.,о.,д.;и.,т..с.:я,, ..н.;а., .,k;,i..b.:e,;r.,i.,s.,.;.r.:u,
⌂ / Active ingredients /
 Share

Chlormethylsilatran

Check Analogs Compare
  1. Pharmacological Group
  2. Latin name
  3. ATX code
  4. Nosology
  5. Characteristics of the substance
  6. Analogs by action
  7. Included in the composition

Pharmacological Group

Dermatotropic products

Latin name

 Chlormethylsilatranum ( сhlormethylsilatrani)[[g.
 Дерматотропные средства.

ATX code

 D11AX Препараты для лечения заболеваний кожи другие.

Nosology

 • L63 Гнездная алопеция.

Characteristics of the substance

 Комбинированный препарат, представляющий собой двухфазный раствор: верхний слой слегка окрашен в желтый цвет, нижний - бесцветный.[[d.
 Фармакологическое действие - стимулирующее рост волос.[[p.
 Очаговая алопеция.[[r.
 Гиперчувствительность, перенесенный инфаркт миокарда, возраст (до 15 и старше 60 лет).[[b.
 Противопоказано.[[e.
 Дерматит, жжение, зуд.[[ф.
 Описание было автоматически дополнено из инструкции препарата «Силокаст», поскольку у самого действующего вещества нет подробного описания.

Analogs by action

Included in the composition

42a96bb5c8a2acfb07fc866444b97bf1
✘Available only when using PRO account
Content moderator: Vasin A. S.


  1. Kiberis is NOT an online store and does NOT purchase, store, sell or deliver drugs. The resource acts only as an intermediary between you and the manufacturer of drugs or pharmacy points, which carry out the delivery.
  2. On Kiberis there are descriptions of drugs, some of which are intended only for doctors. This information cannot be used by patients to make decisions about the use of drugs, their cancellation or correction of dosages.
  3. Nothing in the information provided should be interpreted as a call to use these drugs.
  4. No claims can be made to Kiberis regarding any damage or harm incurred as a result of the use of the information posted on the site.